Does HYALURONIDASE Cause Supraventricular tachycardia? 6 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Supraventricular tachycardia have been filed in association with HYALURONIDASE (Phesgo). This represents 0.5% of all adverse event reports for HYALURONIDASE.
6
Reports of Supraventricular tachycardia with HYALURONIDASE
0.5%
of all HYALURONIDASE reports
1
Deaths
5
Hospitalizations
How Dangerous Is Supraventricular tachycardia From HYALURONIDASE?
Of the 6 reports, 1 (16.7%) resulted in death, 5 (83.3%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Supraventricular tachycardia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HYALURONIDASE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does HYALURONIDASE Cause?
Fatigue (375)
Alopecia (358)
Abdominal discomfort (355)
Arthralgia (349)
Diarrhoea (330)
Headache (328)
Hypertension (325)
Blood cholesterol increased (320)
Arthropathy (318)
Off label use (315)
What Other Drugs Cause Supraventricular tachycardia?
ADALIMUMAB (141)
METOPROLOL (132)
ROSIGLITAZONE (114)
TREPROSTINIL (113)
RITUXIMAB (99)
ALBUTEROL (98)
IBRUTINIB (96)
DEXAMETHASONE (95)
ASPIRIN (92)
LEVOTHYROXINE (91)
Which HYALURONIDASE Alternatives Have Lower Supraventricular tachycardia Risk?
HYALURONIDASE vs HYALURONIDASE-OCSQ\OCRELIZUMAB
HYALURONIDASE vs HYALURONIDASE \RITUXIMAB
HYALURONIDASE vs HYALURONIDASE-ZZXF\PERTUZUMAB\TRASTUZUMAB
HYALURONIDASE vs HYDRALAZINE
HYALURONIDASE vs HYDRALAZINE\ISOSORBIDE DINITRATE